These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 9587162

  • 1. Prostaglandin E1 in peripheral vascular disease: a PET study of muscular blood flow.
    Schellong SM, Burchert W, Böger RM, Creutzig A, Hundeshagen H, Alexander K.
    Scand J Clin Lab Invest; 1998 Apr; 58(2):109-17. PubMed ID: 9587162
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Endothelial function in patients with peripheral vascular disease: influence of prostaglandin E1.
    Weiss T, Fischer D, Hausmann D, Weiss C.
    Prostaglandins Leukot Essent Fatty Acids; 2002 Nov; 67(5):277-81. PubMed ID: 12445486
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Neutrophil function in peripheral arterial occlusive disease: the effects of prostaglandin E1.
    Weiss T, Eckstein H, Weiss C, Diehm C.
    Vasc Med; 1998 Nov; 3(3):171-5. PubMed ID: 9892509
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Progress in the prostaglandin E1-therapy of the intermittent claudication by means of bolus injections of LIPO-prostaglandin E1 (LIPO-PGE1).
    Scheffler P, Gross J, Markwirth T, Maier J, Schieffer H.
    Eur J Clin Pharmacol; 1996 Nov; 51(3-4):235-9. PubMed ID: 9010691
    [Abstract] [Full Text] [Related]

  • 8. Haemodynamic effects of intra-arterial and intravenous administration of prostaglandin E1 in patients with peripheral arterial disease.
    Hirai M, Nakayama R.
    Br J Surg; 1986 Jan; 73(1):20-3. PubMed ID: 3947867
    [Abstract] [Full Text] [Related]

  • 9. Effects of prostaglandin E1 infusion on limb hemodynamics and vasodilatory response in patients with arteriosclerosis obliterans.
    Makita S, Nakamura M, Ohhira A, Itoh S, Hiramori K.
    Cardiovasc Drugs Ther; 1997 Jul; 11(3):441-8. PubMed ID: 9310272
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of intravenous and intra-arterial infusions of prostaglandin E1 on canine hindlimb blood flow distribution.
    Lynch TG, Hobson RW, Barbalinardo JP, Kerr JC.
    Surgery; 1984 Jul; 96(1):35-41. PubMed ID: 6539953
    [Abstract] [Full Text] [Related]

  • 13. Comparison of stellate ganglion block with intravascular infusion of prostaglandin E1 on brachial artery blood flow in dogs.
    Okuda Y, Kitajima T.
    Anesth Analg; 1997 Jun; 84(6):1329-32. PubMed ID: 9174315
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ocular and orbital blood flow velocity in patients with peripheral vascular disease and diabetes treated with intravenous prostaglandin E1.
    Steigerwalt RD, Belcaro GV, Christopoulos V, Incandela L, Cesarone MR, De Sanctis MT.
    J Ocul Pharmacol Ther; 2001 Dec; 17(6):529-35. PubMed ID: 11777176
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of prolonged intra-arterial prostaglandin E1 infusion on canine arterial graft patency.
    Cronenwett JL, Shapiro DM, Luce JL.
    Arch Surg; 1986 Jul; 121(7):760-4. PubMed ID: 3718209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.